Better Life Pharma (CSE: BETR – OTCQB: BETRF) CEO Ahmad Doroudian joined Steve Darling from Proactive to bring news the company is ready to take the next step in their research after closing two financings and being selected for more financing with the Mitacs Accelerate program.
Doroudian telling Proactive about being selected by Mitacs. He also shared with Proactive where their pre-clinical work is at what they are planning on their Anti-Viral program to move it forward.